OVID

MKT CAP:$478M

Ovid Therapeutics Inc

Market Cap

$478M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$2.40+$0.64 (+36.36%)

Jun 5, 2026

52W High $2.9652W Low $0.28

Company Details

Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of small molecule medicines for brain disorders including epilepsies and seizure-related neurological disorders in the United States. The company is developing ...

CEO

—

IPO Date

May 5, 2017

Website

www.ovidrx.com

Key Metrics TTM

Revenue

$7M

+1199.6% YoY

Net Income

-$24M

EPS (Diluted)

Free Cash Flow

-$42M

Revenue / Share

$0.10

Gross Margin

99.5%

Operating Margin

-670.2%

Net Margin

-339.3%

FCF Margin

-589.1%

P/S

67.1x

P/E

Earnings Reports

Q1 2026

May 12, 2026

$0-100.0%

FY 2025

Mar 18, 2026

$7M+1181.3%

Q4 2025

Mar 18, 2026

$718.0K+844.7%

Q3 2025

Nov 12, 2025

$132.0K-23.7%

Q2 2025

Aug 13, 2025

$6M+3611.2%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee